Nuclear Medicine Theranostics: Perspective from Pakistan

Abstract

Nuclear medicine has been offering diagnostic and therapeutic solution since the introduction of radioactive iodine for thyroid diseases since decades. However, the concept of theranostics has given a new found impetus to the use of pairs of radiopharmaceuticals for diagnosis and treatment. Presented here is a perspective on theranostics from Pakistan.

Regulación de los servicios de medicina nuclear: percepción de la problemática y desafíos para el manejo del cáncer en Colombia

“…Por ejemplo, en Pakistán la mayor oferta de servicios de medicina nuclear la brinda la Comisión de Energía Atómica de Pakistán y la terapia con yodo radiactivo para el tratamiento ambulatorio está más disponible en todo el país. Las instalaciones para pacientes hospitalizados para administrar dosis altas son limitadas, pero dada la distribución de los centros en todo el país, se cubre una gran parte del territorio (38).…”

Nuclear Theranostics in Asia: In vivo Companion Diagnostics

“…In this issue [12][13][14][15][16] and online [37][38][39][40][41][42] and also the following issues, we will see the current status of state-of-art theranostics in Asian countries, however, beyond the geographic extension of nuclear theranostics, disciplinary expansion above the current obsession with peptides or small molecules, or above a few successful tumors are to be expected with full inspiration in our collective mind of nuclear medicine community. Asian colleagues and also all the colleagues, either current or next-generation leaders, regardless of their nationality with various economic status of their own countries, will develop the novel in vivo theranostics including nuclear theranostics.…”